eXoZymes, Inc.
EXOZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $267 | $0 | $148 | $59 |
| Gross Profit | -$267 | $0 | -$148 | -$59 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,869 | $527 | $348 | $454 |
| G&A Expenses | $0 | $1,339 | $0 | $0 |
| SG&A Expenses | $3,796 | $1,339 | $837 | $779 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$70 | $0 | $0 |
| Operating Expenses | $5,665 | $1,796 | $1,185 | $1,233 |
| Operating Income | -$5,932 | -$1,796 | -$1,333 | -$1,293 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $71 | -$200 | $0 | $84 |
| Pre-Tax Income | -$5,861 | -$1,996 | -$1,333 | -$1,209 |
| Tax Expense | $0 | $42 | $64 | $0 |
| Net Income | -$5,861 | -$2,038 | -$1,396 | -$1,209 |
| % Margin | – | – | – | – |
| EPS | -0.72 | -0.25 | -0.17 | -0.15 |
| % Growth | -188% | -47.1% | -13.3% | – |
| EPS Diluted | -0.72 | -0.25 | -0.17 | -0.15 |
| Weighted Avg Shares Out | 8,127 | 8,127 | 8,127 | 8,127 |
| Weighted Avg Shares Out Dil | 8,127 | 8,127 | 8,127 | 8,127 |
| Supplemental Information | – | – | – | – |
| Interest Income | $78 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $267 | $197 | $148 | $59 |
| EBITDA | -$5,594 | -$1,599 | -$1,185 | -$1,150 |
| % Margin | – | – | – | – |